Wave Aspires To Accelerated Approval In DMD With 48-Week Data

 
• By Joseph Haas
  
DMD
Wave looks to accelerated approval for its Phase III Duchenne muscular dystrophy candidate • Source: Shutterstock

More from Strategy

More from Therapy Areas